126 related articles for article (PubMed ID: 25188004)
1. Subcutaneously injected ivermectin-loaded mixed micelles: formulation, pharmacokinetics and local irritation study.
Dong J; Song X; Lian X; Fu Y; Gong T
Drug Deliv; 2016 Sep; 23(7):2220-2227. PubMed ID: 25188004
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicity in vitro.
Duan Y; Wang J; Yang X; Du H; Xi Y; Zhai G
Drug Deliv; 2015 Jan; 22(1):50-7. PubMed ID: 24417664
[TBL] [Abstract][Full Text] [Related]
3. Alpha-Asarone incorporated in mixed micelles suitable for intravenous administration: formulation, in-vivo distribution and anaphylaxis study.
Ren C; Gong T; Sun X; Zhang Z; Zhang Y
Pharmazie; 2011 Nov; 66(11):875-80. PubMed ID: 22204134
[TBL] [Abstract][Full Text] [Related]
4. Nimodipine-loaded mixed micelles: formulation, compatibility, pharmacokinetics, and vascular irritability study.
Song X; Jiang Y; Ren C; Sun X; Zhang Q; Gong T; Zhang Z
Int J Nanomedicine; 2012; 7():3689-99. PubMed ID: 22888228
[TBL] [Abstract][Full Text] [Related]
5. Design of controlled-release formulation for ivermectin using silicone.
Maeda H; Brandon M; Sano A
Int J Pharm; 2003 Aug; 261(1-2):9-19. PubMed ID: 12878391
[TBL] [Abstract][Full Text] [Related]
6. Mixed nanomicelles loaded with thymopeptides-sodium deoxycholate/phospholipid improve drug absorption.
Shi-Xiao J; Shi-Ying J; Lv QY; Shan-Shan F; Jin H; Yuan HL
Chin J Nat Med; 2014 Jan; 12(1):65-70. PubMed ID: 24484599
[TBL] [Abstract][Full Text] [Related]
7. Sustained release ivermectin-loaded solid lipid dispersion for subcutaneous delivery: in vitro and in vivo evaluation.
Lu M; Xiong D; Sun W; Yu T; Hu Z; Ding J; Cai Y; Yang S; Pan B
Drug Deliv; 2017 Nov; 24(1):622-631. PubMed ID: 28282989
[TBL] [Abstract][Full Text] [Related]
8. Sodium deoxycholate mediated enhanced solubilization and stability of hydrophobic drug Clozapine in pluronic micelles.
Singla P; Singh O; Chabba S; Aswal VK; Mahajan RK
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Feb; 191():143-154. PubMed ID: 29028506
[TBL] [Abstract][Full Text] [Related]
9. Improvement of oral bioavailability of glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicelles.
Jin S; Fu S; Han J; Jin S; Lv Q; Lu Y; Qi J; Wu W; Yuan H
J Drug Target; 2012 Aug; 20(7):615-22. PubMed ID: 22726209
[TBL] [Abstract][Full Text] [Related]
10. Increasing drug solubility by means of bile salt-phosphatidylcholine-based mixed micelles.
Hammad MA; Müller BW
Eur J Pharm Biopharm; 1998 Nov; 46(3):361-7. PubMed ID: 9885310
[TBL] [Abstract][Full Text] [Related]
11. Mucoadhesive buccal films containing phospholipid-bile salts-mixed micelles as an effective carrier for Cucurbitacin B delivery.
Lv Q; Shen C; Li X; Shen B; Yu C; Xu P; Xu H; Han J; Yuan H
Drug Deliv; 2015 May; 22(3):351-8. PubMed ID: 24467528
[TBL] [Abstract][Full Text] [Related]
12. Ivermectin disposition kinetics after subcutaneous and intramuscular administration of an oil-based formulation to cattle.
Lifschitz A; Virkel G; Pis A; Imperiale F; Sanchez S; Alvarez L; Kujanek R; Lanusse C
Vet Parasitol; 1999 Oct; 86(3):203-15. PubMed ID: 10511102
[TBL] [Abstract][Full Text] [Related]
13. [Preparation and characterization of cucurbitacin B sodium deoxycholate/phospholipid-mixed oral fast dissolving film and antitumor activity study].
Yu C; Xiao YZ; Xun PH; Dai L; Han J; Yuan HL
Zhongguo Zhong Yao Za Zhi; 2014 May; 39(10):1799-804. PubMed ID: 25282885
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence of ivermectin formulations in pigs and cattle.
Lifschitz A; Pis A; Alvarez L; Virkel G; Sanchez S; Sallovitz J; Kujanek R; Lanusse C
J Vet Pharmacol Ther; 1999 Feb; 22(1):27-34. PubMed ID: 10211714
[TBL] [Abstract][Full Text] [Related]
15. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
Liu J; Gong T; Wang C; Zhong Z; Zhang Z
Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
[TBL] [Abstract][Full Text] [Related]
16. Preliminary investigation on the design of biodegradable microparticles for ivermectin delivery: set up of formulation parameters.
Dorati R; Genta I; Colzani B; Tripodo G; Conti B
Drug Dev Ind Pharm; 2015; 41(7):1182-92. PubMed ID: 24994001
[TBL] [Abstract][Full Text] [Related]
17. Ivermectin-loaded lipid nanocapsules: toward the development of a new antiparasitic delivery system for veterinary applications.
Gamboa GV; Palma SD; Lifschitz A; Ballent M; Lanusse C; Passirani C; Benoit JP; Allemandi DA
Parasitol Res; 2016 May; 115(5):1945-53. PubMed ID: 26852126
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the long-acting ivermectin formulation in sheep: Further insight into potential pharmacokinetic interactions.
Ballent M; Maté ML; Dominguez P; Virkel G; Albérich M; Lespine A; Lanusse C; Lifschitz AL
J Vet Pharmacol Ther; 2019 Mar; 42(2):189-196. PubMed ID: 30520071
[TBL] [Abstract][Full Text] [Related]
19. Ivermectin (3.15%) long-acting formulations in cattle: absorption pattern and pharmacokinetic considerations.
Lifschitz A; Virkel G; Ballent M; Sallovitz J; Imperiale F; Pis A; Lanusse C
Vet Parasitol; 2007 Jul; 147(3-4):303-10. PubMed ID: 17524559
[TBL] [Abstract][Full Text] [Related]
20. Physical and pharmacokinetic characterization of Soluvec™, a novel, solvent-free aqueous ivermectin formulation.
Mandalaywala R; Rana A; Ramos AL; Sampson P; Ashkenas J
Ther Deliv; 2023 Jun; 14(6):391-399. PubMed ID: 37535333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
